Costs of nosocomial infections in the ICU and impact of programs to reduce risks and costs

Clinical Pulmonary Medicine

Volumn 9, Issue 1, 2002, Pages 33-38

  Durand Zaleski, Isabelle ^a   Chaix, Carine ^a   Brun Buisson, Christian ^a  

^a Service de Santé Publique   (France)

Author keywords

Costs; Economics; Guidelines; ICU; Nosocomial infections

Indexed keywords

ANTIINFECTIVE AGENT;

ARTICLE; COST BENEFIT ANALYSIS; DISEASE SEVERITY; DRUG COST; ECONOMIC EVALUATION; HEALTH CARE COST; HEALTH PROGRAM; HOSPITAL INFECTION; HOSPITALIZATION; INTENSIVE CARE; LENGTH OF STAY; PRACTICE GUIDELINE; PRIMARY PREVENTION; SCREENING;

EID: 0036144632     PISSN: 10680640     EISSN: None     Source Type: Journal    
DOI: 10.1097/00045413-200201000-00005     Document Type: Article

References (46)

1. Nosocomial infections, diagnosis-related groups, and study on the efficacy of nosocomial infection control. Economic implications for hospitals under the prospective payment system
2. Selected aspects of the socioeconomic impact of nosocomial infections: Morbidity, mortality, cost, and prevention
3. Public health: Surveillance, prevention, and control of nosocomial infections
4. Discrepancy between medical decisions for individual patients and for groups
5. Why some health policies don't make sense at the bedside
6. Methods for estimating days of hospitalization due to nosocomial infections
7. A review of cost studies of intensive care unit: Problems with the cost concept
8. Eradication of endemic methicillin-resistant Staphylococcus aureus infections from a neonatal intensive care unit
9. Should we vigorously try to contain and control methicillin-resistant Staphylococcus aureus?
10. Epidemiology of nosocomial infections caused by methicillin-resistant Staphylococcus aureus
11. Methicillin-resistant Staphylococcus aureus control in hospitals: The Dutch experience
12. Trying to control MRSA causes more problems than it solves
13. The disappearance of multiresistant Staphylococcus aureus in Denmark: Changes in strains of the 83A complex between 1969 and 1989
14. Guidelines for the prevention of drug resistance in hospitals
15. Control of endemic methicillin-resistant Staphylococcus aureus: A cost-benefit analysis in an intensive care unit
16. Undetected vancomycin-resistant Enterococcus in surgical intensive care unit patients
17. Failure to eradicate vancomycin-resistant enterococci in a university hospital and the cost of barrier precautions
18. Evaluation of clinical practice guidelines on outcome of infection in patients in the surgical intensive care unit
19. Economic impact of a rational use of antibiotics in intensive care
20. Cost of nosocomial infection: Analysis of 512 digestive surgery patients
21. Incidence, etiology, and outcome of nosocomial pneumonia in mechanically ventilated patients
22. Pharmacoeconomic analysis of cefmenoxime dual individualization in the treatment of nosocomial pneumonia
23. The effect of late-onset ventilator-associated pneumonia in determining patient mortality
24. Nosocomial pneumonia in ventilated patients: A cohort study evaluating attributable mortality and hospital stay
25. Prolongation of hospital stay and extra costs due to ventilator-associated pneumonia in an intensive care unit
26. Effect of intensive care unit nosocomial pneumonia on duration of stay and mortality
27. Nosocomial pneumonia in medicare patients
28. Nosocomial bloodstream infection in critically ill patients: Excess length of stay, extra costs, and attributable mortality
29. Coagulase-negative staphylococcal bacteremia among very low birth weight infants: Relation to admission illness severity, resource use and outcome
30. Influence of nosocomial infection on mortality rate in intensive care unit
31. Nosocomial acquisition of multiresitant Acinetobacter baumannii: Risk factors and prognosis
32. Le coûat de l'infection nosocomiale en réanimation: Une évaluation médi-cale et économique
33. Shortcourse empiric antibiotic therapy for patients with pulmonary infiltrates in the intensive care unit. A proposed solution for indiscriminate antibiotic prescription
34. Prolongation of hospital stay and extra costs due to hospital-acquired infection in a neonatal unit
35. Evaluation of Acinetobacter baumannii infection and colonization, and antimicrobial treatment patterns in an urban teaching hospital
36. The impact of surgical-site infections in the 1990s: Attributable mortality, excess length of hospitalization, and extra costs
37. Quantifying excess length of postoperative stay attributable to infections: A comparison of methods
38. The attributable mortality and costs of primary nosocomial bloodstream infections in the intensive care unit
39. Evaluation of outcome of intravenous catheter-related infections in critically ill patients
40. Influence of an infectious disease service on antibiotic prescription behavior and selection of multiresistant pathogens
41. The impact of a multidisciplinary approach on caring for ventilator-dependent patients
42. Vancomycin use in a university medical center: Effect of avancomycin continuation form
43. Risk factors and outcome of nosocomial infections: Results of a matched case-control study of ICU patients
44. Cost-effectiveness of antiseptic-impregnated central venous catheters for the prevention of catheter-related bloodstream infection
45. Prevention of central venous catheter-related bloodstream infection by use of an antiseptic-impregnated catheter. A randomized, controlled trial